Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human vs Analog Insulin in Acute Stroke Hyperglycemia
NCT04834362Phase 4Completed
- Sponsor
- National Institute of Neurosciences and Hospital
- Start
- Apr 2021
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin aspart in hyperglycemia, sponsored by National Institute of Neurosciences and Hospital. Started Apr 2021; status: completed.
02
Drugs
insulin glargineinsulin aspart
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT04834362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04834362.